AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionSfmg, Llc
Latest Disclosed Ownership6,024 shares
Latest Disclosed Value $ 1,310,167
Sfmg, Llc reports 3.33% increase in ownership of 4AB / AbbVie Inc.

On May 12, 2026 - Sfmg, Llc filed a 13F-HR form disclosing ownership of 6,024 shares of AbbVie Inc. (DE:4AB) valued at $1,116,850 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 5,830 shares of AbbVie Inc.. This represents a change in shares of 3.33% during the quarter. The current value of the position is $1,135,524 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE COM 00287Y109 6,024 194 3.33 1,310 -1.65 0.0885
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 5,830 157 2.77 1,332 1.45 0.0893
2025-11-13 2025-09-30 13F ABBVIE COM 00287Y109 5,673 22 0.39 1,313 25.29 0.0911
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 5,651 -823 -12.71 1,049 -22.71 0.0787
2025-05-09 2025-03-31 13F ABBVIE COM 00287Y109 6,474 -581 -8.24 1,357 8.22 0.1071
2025-02-11 2024-12-31 13F ABBVIE COM 00287Y109 7,055 -5 -0.07 1,254 -10.11 0.0988
2024-11-25 2024-09-30 13F ABBVIE COM 00287Y109 7,060 -31 -0.44 1,394 14.64 0.1130
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 7,091 -29 -0.41 1,216 -6.17 0.1057
2024-05-07 2024-03-31 13F ABBVIE COM 00287Y109 7,120 -392 -5.22 1,297 11.34 0.1115
2024-01-30 2023-12-31 13F ABBVIE COM 00287Y109 7,512 -429 -5.40 1,164 -1.61 0.1079
2023-11-06 2023-09-30 13F ABBVIE COM 00287Y109 7,941 247 3.21 1,184 14.19 0.1217
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 7,694 -63 -0.81 1,037 -16.18 0.1067
2023-05-01 2023-03-31 13F ABBVIE COM 00287Y109 7,757 923 13.51 1,236 11.96 0.1331
2023-01-25 2022-12-31 13F ABBVIE COM 00287Y109 6,834 -11,941 -63.60 1,104 -57.99 0.1226
2022-10-20 2022-09-30 13F ABBVIE COM 00287Y109 18,775 115 0.62 2,628 -8.05 0.3067
2022-08-08 2022-06-30 13F ABBVIE COM 00287Y109 18,660 -5,808 -23.74 2,858 -27.96 0.3316
2022-04-21 2022-03-31 13F ABBVIE COM 00287Y109 24,468 -11,884 -32.69 3,967 -19.40 0.3922
2022-01-31 2021-12-31 13F ABBVIE COM 00287Y109 36,352 1,524 4.38 4,922 31.01 0.4784
2021-11-01 2021-09-30 13F ABBVIE COM 00287Y109 34,828 253 0.73 3,757 -3.54 0.4168
2021-08-06 2021-06-30 13F ABBVIE COM 00287Y109 34,575 -116 -0.33 3,895 3.76 0.4326
2021-05-03 2021-03-31 13F ABBVIE COM 00287Y109 34,691 2,084 6.39 3,754 7.44 0.4352
2021-02-02 2020-12-31 13F ABBVIE COM 00287Y109 32,607 1,718 5.56 3,494 29.12 0.4431
2020-11-12 2020-09-30 13F ABBVIE COM 00287Y109 30,889 4,835 18.56 2,706 5.79 0.3732
2020-08-03 2020-06-30 13F ABBVIE COM 00287Y109 26,054 432 1.69 2,558 31.05 0.3645
2020-05-08 2020-03-31 13F ABBVIE COM 00287Y109 25,622 -190 -0.74 1,952 -14.57 0.2927
2020-02-05 2019-12-31 13F ABBVIE COM 00287Y109 25,812 -1,431 -5.25 2,285 10.76 0.2795
2019-11-12 2019-09-30 13F/A-1 ABBVIE COM 00287Y109 27,243 9,293 51.77 2,063 69.65 0.2793
2019-10-29 2019-09-30 13F ABBVIE COM 00287Y109 27,243 9,293 2,063 0.2793
2019-08-05 2019-06-30 13F ABBVIE COM 00287Y109 17,950 12,659 239.26 1,216 185.45 0.1650
2019-05-13 2019-03-31 13F ABBVIE COM 00287Y109 5,291 173 3.38 426 -9.75 0.0616
2019-02-12 2018-12-31 13F ABBVIE COM 00287Y109 5,118 -42 -0.81 472 14.84 0.0763
2018-11-15 2018-09-30 13F ABBVIE COM 00287Y109 5,160 350 7.28 411 -7.85 0.0632
2018-08-08 2018-06-30 13F ABBVIE COM 00287Y109 4,810 100 2.12 446 0.00 0.0723
2018-05-10 2018-03-31 13F ABBVIE COM 00287Y109 4,710 50 1.07 446 -1.11 0.0756
2018-02-09 2017-12-31 13F ABBVIE COM 00287Y109 4,660 985 26.80 451 37.92 0.0749
2017-11-07 2017-09-30 13F ABBVIE COM 00287Y109 3,675 21 0.57 327 23.40 0.0639
2017-08-07 2017-06-30 13F ABBVIE COM 00287Y109 3,654 -724 -16.54 265 -7.02 0.0550
2017-05-01 2017-03-31 13F ABBVIE COM 00287Y109 4,378 4,378 285 0.0577
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.